These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 21753124)

  • 21. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells.
    Molnár J; Hevér A; Fakla I; Fischer J; Ocsovski I; Aszalós A
    Anticancer Res; 1997; 17(1A):481-6. PubMed ID: 9066699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efflux pumps: their role in Staphylococcus aureus antibiotic resistance].
    Doléans-Jordheim A; Michalet S; Bergeron E; Boisset S; Souard F; Dumontet C; Dijoux-Franca MG; Freney J
    Ann Biol Clin (Paris); 2008; 66(5):499-508. PubMed ID: 18957338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of demethylfruticuline A and fruticuline A from Salvia corrugata Vahl. on biofilm production in vitro by multiresistant strains of Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis.
    Schito AM; Piatti G; Stauder M; Bisio A; Giacomelli E; Romussi G; Pruzzo C
    Int J Antimicrob Agents; 2011 Feb; 37(2):129-34. PubMed ID: 21163629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial activities of some tetrahydronaphthalene-benzimidazole derivatives.
    Ates-Alagoz Z; Yildiz S; Buyukbingol E
    Chemotherapy; 2007; 53(2):110-3. PubMed ID: 17310118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substituted dihydronaphthalenes as efflux pump inhibitors of Staphylococcus aureus.
    Thota N; Reddy MV; Kumar A; Khan IA; Sangwan PL; Kalia NP; Koul JL; Koul S
    Eur J Med Chem; 2010 Sep; 45(9):3607-16. PubMed ID: 20605275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of antibiotic efflux in bacteria by the novel multidrug resistance inhibitors biricodar (VX-710) and timcodar (VX-853).
    Mullin S; Mani N; Grossman TH
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4171-6. PubMed ID: 15504837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catechin gallates inhibit multidrug resistance (MDR) in Staphylococcus aureus.
    Gibbons S; Moser E; Kaatz GW
    Planta Med; 2004 Dec; 70(12):1240-2. PubMed ID: 15643566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of 2-mercapto-1,3-benzothiazole derivatives with potential antimicrobial activity.
    Franchini C; Muraglia M; Corbo F; Florio MA; Di Mola A; Rosato A; Matucci R; Nesi M; van Bambeke F; Vitali C
    Arch Pharm (Weinheim); 2009 Oct; 342(10):605-13. PubMed ID: 19753564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel inhibitory activity of the Staphylococcus aureus NorA efflux pump by a kaempferol rhamnoside isolated from Persea lingue Nees.
    Holler JG; Christensen SB; Slotved HC; Rasmussen HB; Gúzman A; Olsen CE; Petersen B; Mølgaard P
    J Antimicrob Chemother; 2012 May; 67(5):1138-44. PubMed ID: 22311936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation.
    Schumacher A; Trittler R; Bohnert JA; Kümmerer K; Pagès JM; Kern WV
    J Antimicrob Chemother; 2007 Jun; 59(6):1261-4. PubMed ID: 16971414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An instrument-free method for the demonstration of efflux pump activity of bacteria.
    Martins M; Santos B; Martins A; Viveiros M; Couto I; Cruz A; Pagès JM; Molnar J; Fanning S; Amaral L; ; ;
    In Vivo; 2006; 20(5):657-64. PubMed ID: 17091774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-caffeoylphenalkylamide derivatives as bacterial efflux pump inhibitors.
    Michalet S; Cartier G; David B; Mariotte AM; Dijoux-franca MG; Kaatz GW; Stavri M; Gibbons S
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1755-8. PubMed ID: 17275293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efflux-mediated antibiotics resistance in bacteria].
    Cattoir V
    Pathol Biol (Paris); 2004 Dec; 52(10):607-16. PubMed ID: 15596311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles.
    Holler JG; Slotved HC; Mølgaard P; Olsen CE; Christensen SB
    Bioorg Med Chem; 2012 Jul; 20(14):4514-21. PubMed ID: 22682300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cme gene of Clostridium difficile confers multidrug resistance in Enterococcus faecalis.
    Lebel S; Bouttier S; Lambert T
    FEMS Microbiol Lett; 2004 Sep; 238(1):93-100. PubMed ID: 15336408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the AraC-XylS family regulator YdeO in multi-drug resistance of Escherichia coli.
    Nishino K; Senda Y; Hayashi-Nishino M; Yamaguchi A
    J Antibiot (Tokyo); 2009 May; 62(5):251-7. PubMed ID: 19329985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carnosic acid is an efflux pumps modulator by dissipation of the membrane potential in Enterococcus faecalis and Staphylococcus aureus.
    Ojeda-Sana AM; Repetto V; Moreno S
    World J Microbiol Biotechnol; 2013 Jan; 29(1):137-44. PubMed ID: 22961443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From 6-aminoquinolone antibacterials to 6-amino-7-thiopyranopyridinylquinolone ethyl esters as inhibitors of Staphylococcus aureus multidrug efflux pumps.
    Pieroni M; Dimovska M; Brincat JP; Sabatini S; Carosati E; Massari S; Kaatz GW; Fravolini A
    J Med Chem; 2010 Jun; 53(11):4466-80. PubMed ID: 20446747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of overexpression of small non-coding DsrA RNA on multidrug efflux in Escherichia coli.
    Nishino K; Yamasaki S; Hayashi-Nishino M; Yamaguchi A
    J Antimicrob Chemother; 2011 Feb; 66(2):291-6. PubMed ID: 21088020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli.
    Kern WV; Steinke P; Schumacher A; Schuster S; von Baum H; Bohnert JA
    J Antimicrob Chemother; 2006 Feb; 57(2):339-43. PubMed ID: 16354747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.